Skip to content

Clinical trials

Lung Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: South Korea Clear all

236 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20054
20068
20075
20088
20097
20104
20118
20129
20138
20145
201513
20169
20179
201813
201911
202012
202126
202214
202311
202422
202515
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95
Unknown status49
Recruiting39
Active, not recruiting26
Terminated19
Not yet recruiting4
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center19
National Cancer Center, Korea15
Yonsei University15
Novartis Pharmaceuticals13
AstraZeneca12
Seoul National University Hospital11
Pfizer7
Bristol-Myers Squibb6
Eli Lilly and Company6
Asan Medical Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms236
Carcinoma, Non-Small-Cell Lung113
Neoplasms30
Neoplasm Metastasis22
Lung Diseases18
Colorectal Neoplasms17
Carcinoma15
Head and Neck Neoplasms15
Respiratory Tract Diseases14
Adenocarcinoma of Lung13

Trials

Showing 26 to 50 of 236. Each trial links to its page on Pharma Observatory.

136 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.